Lakeshore Biopharma Co Ltd's ROA from the fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Lakeshore Biopharma Co Ltd's ROA in the fourth quarter of 2024?
Lakeshore Biopharma Co Ltd recorded a cumulative net loss of $-61 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on assets (ROA) of -27.93%.

However, within the Healthcare sector 210 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2024 from to 3967.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Mar 31 2023) IV. Quarter
Y / Y Total Assets Change	124.25 %	-14.62 %	-14.79 %	-14.79 %	-0.7 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-61	-21	-21	-21	-21
Return On Assets (TTM)	-27.93 %	-11.37 %	-10.84 %	-10.35 %	-9.9 %
LSB's Total Ranking	# 3967	#	#	#	#
Total Assets (TTM) in million	235	214	213	213	105
Seq. Total Assets Change	9.94 %	0.2 %	0 %	103.56 %	-58.14 %
Seq. Net Income Change	-	-	-	-	-

LSB's 5 Years Annual ROA >> Back to LSB Management Effectiveness >> Compare LSB ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 72
Sector	# 211
Overall	# 2816

Return On Assets Statistics
High	Average	Low
-1.02 %	-14.84 %	-28.65 %
(Mar 31 2025)		(Mar 31 2024)

Financial Statements
Lakeshore Biopharma Co Ltd's Assets	$ 235 million	LSB's Balance sheet
Lakeshore Biopharma Co Ltd's Income	$ -61 million	Quarterly LSB's Income Statement
LSB's Income by Division		See LSB's Income by Division

Annual Return On Assets	(Mar 31 2025) FY 2025	(Mar 31 2024) FY 2024	(Mar 31 2023) FY 2023	FY	FY
Y / Y Total Assets Change	131.31 %	-6.13 %	-	-	-
Total Assets in million	235	102	108	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-2	-61	-21	0	0
Annual Return On Assets	-0.82 %	-60.15 %	-19.57 %	-	-

LSB's 5 Years Annual ROA >> Back to LSB Management Effectiveness >> Compare LSB ROA to its Competitors

More Return On Assets Ratios
LSB's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
LSB's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for LSB's Competitors
Subscribers only: Roa for Lakeshore Biopharma Co Ltd's Suppliers
Subscribers only: Return On Assets for LSB's Customers

You may also want to know
LSB's Roi	LSB's Inventory Turnover Ratio	LSB's Growth Rates	LSB's Dividend Comparisons
	LSB's Profitability Ratios	LSB's Asset Turnover Ratio	LSB's Dividend Growth
LSB's Roe	LSB's Valuation Ratios	LSB's Financial Strength Ratios	LSB's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2024, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:11:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.